Japan’s AI Medical Service, Inc. has secured Breakthrough Device Designation from the FDA for its AI programs that analyze endoscopy images for potential diagnosis of gastric cancer.
How else is AI transforming healthcare?
-
Article
Trustworthy AI: EC High-Level Expert Group Issues Guidelines
Read Now
Thomas Kühler
Global Forum -
Podcast
Digitization Will Return Humanity to Medicine
Listen Now
Robert Califf -
Article
AI in Drug Discovery and Development: Emerging Technologies and Applications
Read Now
Sandra Blumenrath
Global Forum -
Article
Will New Technologies Accelerate Approval of New Therapies? Digital Trials and Sensors, Bots and AI, Oh My!
Read Now
Debra Michaels
Global Forum -
Podcast
Imaging Data Plus AI “One of the Best Combinations”
Listen Now
Kazuhiro Kanmuri -
Article
Improving Clinical Trial Participant Prescreening With AI: Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials
Read Now
Denise Calaprice-Whitty et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Just Buzzwords or Can Innovative Technologies Truly Transform Clinical Trials?
Read Now
Ranjini Prithviraj
Applied Clinical Trials -
Article
Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views
Read Now
Mark Mayer et al.
Therapeutic Innovation & Regulatory Science
Member-only content
Want to learn more?
Insider Access: From our DIA 2019 Global Annual Meeting, watch and learn: Artificial Intelligence in Drug Discovery and Development. Interactive transcript and downloadable audio file to listen on-the-go are also available!